Eli Lilly (LLY) FY2015 results: revenue $20.0 billion, up 1.7% on the year
Eli Lilly & Co. (LLY) reported revenue of $20.0 billion for fiscal 2015, the year ended 31 December 2015, up 1.7% on the year before. Net income was $2.4 billion, up 0.7%, and diluted earnings per share $2.26. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2016.
Revenue
$20.0 billion
+1.7% on the year
FY2008FY2015
Operating margin
n/a
FY2008FY2015
Net income
$2.4 billion
+0.7% on the year
FY2008FY2015
Diluted EPS
$2.26
+1.3% on the year
FY2008FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
19,959
19,616
23,113
+1.7%
Cost of revenue
5,037
4,932
4,908
+2.1%
Gross profit
14,922
14,683
18,205
+1.6%
Gross margin
74.8%
74.9%
78.8%
Research and development
4,796
4,734
5,531
+1.3%
Selling, general and administrative
6,533
6,621
7,126
-1.3%
Interest expense
161
149
160
+8.3%
Pre-tax income
2,790
3,000
5,889
-7.0%
Income tax
382
610
1,204
-37.4%
Effective tax rate
13.7%
20.3%
20.5%
Net income
2,408
2,390
4,685
+0.7%
Net margin
12.1%
12.2%
20.3%
Diluted EPS
$2.26
$2.23
$4.32
+1.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
2,965
4,458
5,735
-33.5%
Capital expenditure
1,066
1,163
1,012
-8.3%
Free cash flow
1,898
3,296
4,723
-42.4%
Free cash flow margin
9.5%
16.8%
20.4%
Cash from investing
26.8
-3,909
-2,073
Cash from financing
-3,111
-166
-3,829
Depreciation and amortisation
1,428
1,379
1,446
+3.5%
Share-based compensation
218
156
145
+39.6%
Buybacks
750
800
1,698
-6.3%
Dividends paid
2,127
2,101
2,121
+1.2%
Diluted shares, weighted
1,066m
1,074m
1,085m
-0.8%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
14,571
15,373
17,631
-5.2%
Non-controlling interest
19.0
14.9
9.3
+27.5%
Debt
7,978
8,022
5,213
-0.5%
Other liabilities
13,000
12,898
12,395
+0.8%
Total liabilities and equity
35,569
36,308
35,249
-2.0%
Fixed assets
8,054
7,964
7,976
+1.1%
Goodwill
4,040
1,758
1,517
+129.8%
Intangible assets
5,035
2,884
2,814
+74.6%
Investments
4,432
5,524
9,192
-19.8%
Cash and equivalents
3,666
3,872
3,830
-5.3%
Receivables
3,513
3,235
3,434
+8.6%
Inventory
3,446
2,740
2,929
+25.8%
Other assets
3,384
8,331
3,557
-59.4%
Total assets
35,569
36,308
35,249
-2.0%
10-K for the year ended 31 December 2015, filed 19 February 2016: the filing.